The majority of patients with the most common advanced or metastatic cancers in the United States do not undergo ...

Emboldened by the success of next-generation sequencing, scientists are pursuing the holy grail of genomics—the '$1,000 genome'—with single-molecule approaches. Nathan Blow reports.

Next Generation Sequencing Market Research, 2035 The global next generation sequencing market is projected to reach $97.8 billion by 2035, ...

Next-generation sequencing (NGS) has become a foundational tool for both biological research and in-vitro diagnostics, particularly in oncology, immunology, and detection of genetic disorders. Despite ...

Quantum-Si Incorporated, The Protein Sequencing Company™, has announced a distribution agreement with Avantor ®, a global leader in mission-critical products and services for the life sciences ...

In fact, some next-generation proteomics companies—notably including Nautilus Biotechnology—are developing affinity-based protein fingerprinting technologies as an end goal.

Delve Bio, a pioneer in metagenomic next-generation sequencing (mNGS) for infectious diseases, will share data about its groundbreaking mNGS test, Delve Detect, at the 2025 American Academy of ...

Next-Gen Sequencing in NSCLC: What Works and What Lies Ahead – An update from Italy's FPG500 program, concurrent DNA-RNA sequencing, and NGS shortcomings.